"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
- PMID: 27973993
- DOI: 10.1056/NEJMoa1610300
"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Abstract
Background: New psychoactive substances constitute a growing and dynamic class of abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass intoxication of 33 persons in one New York City neighborhood, in an event described in the popular press as a "zombie" outbreak because of the appearance of the intoxicated persons.
Methods: We obtained and tested serum, whole blood, and urine samples from 8 patients among the 18 who were transported to local hospitals; we also tested a sample of the herbal "incense" product "AK-47 24 Karat Gold," which was implicated in the outbreak. Samples were analyzed by means of liquid chromatography-quadrupole time-of-flight mass spectrometry.
Results: The synthetic cannabinoid methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (AMB-FUBINACA, also known as MMB-FUBINACA or FUB-AMB) was identified in AK-47 24 Karat Gold at a mean (±SD) concentration of 16.0±3.9 mg per gram. The de-esterified acid metabolite was found in the serum or whole blood of all eight patients, with concentrations ranging from 77 to 636 ng per milliliter.
Conclusions: The potency of the synthetic cannabinoid identified in these analyses is consistent with strong depressant effects that account for the "zombielike" behavior reported in this mass intoxication. AMB-FUBINACA is an example of the emerging class of "ultrapotent" synthetic cannabinoids and poses a public health concern. Collaboration among clinical laboratory staff, health professionals, and law enforcement agencies facilitated the timely identification of the compound and allowed health authorities to take appropriate action.
Comment in
-
Real life zombie apocalypse in New York City.Sci Transl Med. 2017 Feb 1;9(375):eaam6048. doi: 10.1126/scitranslmed.aam6048. Sci Transl Med. 2017. PMID: 28148842
-
"Zombie" Outbreak Caused by Synthetic Cannabinoid.N Engl J Med. 2017 Apr 20;376(16):1597. doi: 10.1056/NEJMc1701936. N Engl J Med. 2017. PMID: 28423303 No abstract available.
-
"Zombie" Outbreak Caused by Synthetic Cannabinoid.N Engl J Med. 2017 Apr 20;376(16):1596-7. doi: 10.1056/NEJMc1701936. N Engl J Med. 2017. PMID: 28425277 No abstract available.
Similar articles
-
A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?Forensic Sci Int. 2019 Apr;297:372-377. doi: 10.1016/j.forsciint.2019.02.005. Epub 2019 Feb 21. Forensic Sci Int. 2019. PMID: 30850157
-
Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.J Anal Toxicol. 2021 Feb 6;45(1):60-68. doi: 10.1093/jat/bkaa054. J Anal Toxicol. 2021. PMID: 32435808
-
Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.Drug Test Anal. 2019 Sep;11(9):1358-1368. doi: 10.1002/dta.2659. Epub 2019 Jul 26. Drug Test Anal. 2019. PMID: 31192526
-
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.Pharmaceuticals (Basel). 2021 Feb 25;14(3):186. doi: 10.3390/ph14030186. Pharmaceuticals (Basel). 2021. PMID: 33669071 Free PMC article. Review.
-
Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.Neuropharmacology. 2018 May 15;134(Pt A):82-91. doi: 10.1016/j.neuropharm.2017.10.017. Epub 2017 Oct 14. Neuropharmacology. 2018. PMID: 29037744 Review.
Cited by
-
Assessment of high-efficacy agonism in synthetic cannabinoid receptor agonists containing l-tert-leucinate.bioRxiv [Preprint]. 2024 Oct 15:2024.10.11.617959. doi: 10.1101/2024.10.11.617959. bioRxiv. 2024. PMID: 39464043 Free PMC article. Preprint.
-
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA.RSC Med Chem. 2024 Apr 10;15(6):2063-2079. doi: 10.1039/d3md00758h. eCollection 2024 Jun 19. RSC Med Chem. 2024. PMID: 38911147
-
A Humanized CB1R Yeast Biosensor Enables Facile Screening of Cannabinoid Compounds.Int J Mol Sci. 2024 May 31;25(11):6060. doi: 10.3390/ijms25116060. Int J Mol Sci. 2024. PMID: 38892247 Free PMC article.
-
The Rise of the inadvertently called Adolescent 'Zombie' Behavior: A Spotlight on Synthetic Cannabinoid Abuse.Braz J Psychiatry. 2024 Jun 14;46:e20243587. doi: 10.47626/1516-4446-2024-3587. Online ahead of print. Braz J Psychiatry. 2024. PMID: 38875494 Free PMC article. No abstract available.
-
CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity.Molecules. 2024 Apr 20;29(8):1881. doi: 10.3390/molecules29081881. Molecules. 2024. PMID: 38675703 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources